IP Library Granted Patent US 10,384,045
Granted Patent B2
US 10,384,045 · App. 14/203,429 · Granted Aug 20, 2019

Microarray with polymer-free microstructures, methods of making, and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,384,045
App. No.
14/203,429
Granted
Aug 20, 2019
Kind
B2
Abstract

A microprojection array comprising an approximately planar base and a plurality of microprojections, wherein the array comprises a therapeutic macromolecule and a stabilizing excipient. Described herein are microstructures having a proximal and distal layer, wherein the distal layer which contains the therapeutic molecule does not rely on the presence of a structure-forming polymer to impart the mechanical strength necessary to penetrate the skin. Methods of forming the array, and methods of using the array are contemplated.

Claims (26)

1. A microstructure apparatus, comprising:

a backing having a first surface and a second surface opposed thereto; and

a microstructure array comprising a plurality of microstructures extending outwardly from the first surface of the backing;

each microstructure in the plurality of microstructures comprising a biodegradable distal layer and at least one proximal layer positioned between the distal layer and the first surface of the backing;

wherein the distal layer comprises between about 50-90% by weight of a therapeutic macromolecule and a stabilizing excipient, and wherein the distal layer does not comprise a structure-forming polymer.

2. The microstructure apparatus of claim 1 , wherein the macromolecule is selected from the group consisting of a polypeptide, a protein, and a monoclonal antibody.

3. The microstructure apparatus of claim 1 , wherein the macromolecule is glycosylated.

4. The microstructure apparatus of claim 1 , wherein the macromolecule is present in each of the plurality of microstructures in an amount of about 0.05 μg to 5 μg.

5. The microstructure apparatus of claim 1 , wherein the stabilizing excipient is a sugar.

6. The microstructure apparatus of claim 1 , wherein the distal layer further comprises a surfactant.

7. The microstructure apparatus of claim 6 , wherein the surfactant is present at a concentration of about 0.01% by weight to 1.0% by weight.

8. The microstructure apparatus of claim 1 , wherein the distal layer further comprises an antioxidant.

9. The microstructure apparatus of claim 1 , wherein the macromolecule has a molecular weight of between about 10,000 Daltons to 1,000,000 Daltons.

10. A microstructure apparatus comprising:

a backing having a first surface and a second surface opposed thereto; and

a microstructure array comprising a plurality of microstructures extending outwardly from the first surface of the backing;

each microstructure in the plurality of microstructures comprising a biodegradable polymer-free distal layer and at least one proximal layer positioned between the polymer-free distal layer and the first surface of the backing;

wherein the polymer-free distal layer is comprised of between about 50-90% by weight of a therapeutic macromolecule with a molecular weight of between about 10,000 Daltons to 1,000,000 Daltons and a balance of a stabilizing excipient and, optionally, an antioxidant.

11. The microstructure apparatus of claim 10 , wherein the at least one therapeutic macromolecule has a molecular weight of between about 100,000 Daltons to 1,000,000 Daltons.

12. The microstructure apparatus of claim 10 , wherein the macromolecule is selected from the group consisting of a polypeptide, a protein, and a monoclonal antibody.

13. The microstructure apparatus of claim 10 , wherein the macromolecule is glycosylated.

14. The microstructure apparatus of claim 10 , wherein the macromolecule is present in each of the plurality of microstructures in an amount of about 0.05 μg to 5 μg.

15. The microstructure apparatus of claim 10 , wherein the stabilizing excipient is a sugar.

16. The microstructure apparatus of claim 10 , wherein the stabilizing excipient is a surfactant.

17. The microstructure apparatus of claim 16 , wherein the surfactant is present in the distal layer at a concentration of about 0.01% by weight to 1.0% by weight.

18. The microstructure apparatus of claim 10 , wherein the distal layer comprises an antioxidant.

Assignments (11)
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER PREVIOUSLY RECORDED AT REEL: 61852 FRAME: 207. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 30, 2025
From: CORIUM, INC.
To: CORIUM PHARMA SOLUTIONS, INC.
Reel/Frame 071915/0691 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2022
From: CORIUM, INC.
To: CORIUM PHARMA SOLUTIONS, INC.
Reel/Frame 062760/0731 →
RELEASE OF SECURITY INTEREST Recorded Oct 19, 2022
From: HERCULES CAPITAL, INC., AS AGENT
To: CORIUM, INC.
Reel/Frame 061713/0557 →
RELEASE OF SECURITY INTEREST Recorded Oct 17, 2022
From: HERCULES CAPITAL, INC.
To: CORIUM, INC.
Reel/Frame 061687/0281 →
SECURITY INTEREST Recorded Oct 17, 2022
From: CORIUM PHARMA SOLUTIONS, INC.
To: SILICON VALLEY BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 061689/0581 →
CHANGE OF NAME Recorded Oct 14, 2022
From: CORIUM, INC.
To: CORIUM PHARMA SOLUTIONS, INC.
Reel/Frame 061852/0207 →
SECURITY INTEREST Recorded Sep 24, 2021
From: CORIUM, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 057597/0907 →
CHANGE OF NAME Recorded Apr 9, 2019
From: CORIUM INTERNATIONAL, INC.
To: CORIUM, INC.
Reel/Frame 048841/0324 →
RELEASE OF SECURITY INTEREST Recorded Mar 6, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "B" (CAYMAN) L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CORIUM INTERNATIONAL, INC.
Reel/Frame 045513/0686 →
SECURITY INTEREST Recorded Dec 4, 2014
From: CORIUM INTERNATIONAL, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II ? PARALLEL FUND ?A? L.P.; CAPITAL ROYALTY PARTNERS II ? PARALLEL FUND ?B? (CAYMAN) L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
Reel/Frame 034535/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2014
From: DING, ZHONGLI; CHEN, GUOHUA; SINGH, PARMINDER
To: CORIUM INTERNATIONAL, INC.
Reel/Frame 032792/0631 →
Cited By (3)
US 12,377,044 US 12,636,250 US 12,708,750